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Abstract 
Background: Emergence of increased antimicrobial resistance of Shigella species is a global challenge, particularly in 
developing countries where increased misuse of antimicrobial agents occurs. There is no published data in the study 
area on the prevalence and antimicrobial susceptibility patterns of Shigella among acute diarrheal patients. This study 
was therefore, under taken to fill this gap.
Methods: Using cross sectional study method, stool specimens were collected from 216 patients with acute diar-
rhea at Mekelle Hospital from August to November 2014. Standard bacteriological methods were used to isolate and 
determine the antimicrobial susceptibility patterns of the isolates, and data were analyzed using SPSS version 20.
Results: Out of the total 216 participants, Shigella was isolated from 15 (6.9 %) of the participants. Ten (66.7 %) of 
the positive isolates were from children <15 years (p = 0.005). Latrine availability, source of drinking water and hand 
washing habits before meal were statistically significant with shigellosis (p < 0.05). Isolates of Shigella showed 100, 
86.7 and 66.7 % resistance to amoxicillin, amoxicillin and cotrimoxazole respectively. Low levels of resistance were 
observed for norfloxacin and ciprofloxacin (6.7 % each). Overall, 80 % of the isolates showed multidrug resistance.
Conclusion: Shigella isolates were highly resistant to amoxicillin, amoxicillin and cotrimoxazole. However, ciprofloxa-
cin and norfloxacin were effective. Antibiotic surveillance is needed to prevent further emergence of drug resistant 
Shigella strains. More has to be done in the availability of latrine, supply of safe drinking water to the community to 
reduce the disease burden.
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Background
Shigellosis is the main cause of public health problem 
throughout the world. The disease is more common in 
resource limited countries. Though Shigella affects all, 
children under five are the most susceptible age group 
[1–3] as a result of poor personal hygiene [4], low immu-
nity and lack of previous exposures [5]. More than 99 % 
of annual episodes of shigellosis with 1.1 million deaths 
have been reported from other developing countries [1]. 
Although the prevalence is less compared to developing 
nations, shigellosis is still a health issue in Europe [2] and 
United States [6].
Studies in Ethiopia showed that Shigellosis is the main 
cause of morbidity and mortality in children [7–15], 
mainly due to inadequate personal and environmental 
hygiene, their low immunity and limited access to safe 
drinking water [16, 17].
Extensive and uncontrolled prescription of antibiot-
ics has led to the emergence of multi drug resistant Shi-
gella strains [18]. This in turn has made it difficult in the 
selection of appropriate antibiotics [19] and effective 
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treatment of shigellosis [20]. Empirical prescription of 
antibiotics by treating physicians is common in Ethiopia 
due to the lack of microbiological laboratory facilities to 
test antimicrobial susceptibility. As a result multi drug 
resistant strains of Shigella have been reported from dif-
ferent regions of the country [9–11, 14, 15].
Studies on shigellosis in Ethiopia were mostly focused 
on children, and most of them were retrospective type. 
The burden of the disease in adults seems to be over-
looked. In contrary, there is no published data from the 
study area (Mekelle town) and the whole Tigray Regional 
State on the prevalence and antimicrobial susceptibility 
patterns of Shigella. Therefore, this study aimed to fill this 
gap by determining the prevalence and antimicrobial sus-
ceptibility patterns of Shigella in all age groups with acute 
diarrhea in Mekelle Hospital. This would complement 
the existing reports from other regions of country to help 
policy makers to have complete data and information as 
an input for further intervention programmes.
Methods
Study area, data collection and transportation
A cross sectional study was conducted in Mekelle general 
hospital from August 2014 to November 2014. Mekelle 
Hospital is the largest regional hospital serving about 6 
million people residing in Tigray, Northern Amhara and 
Western Afar regions. The hospital is located in Mekelle 
city (the capital of Tigray National Regional State). 
Mekelle town is located 784 km North of Addis Ababa, 
the capital city of Ethiopia.
Consenting to participate in the study were obtained 
from patients and/guardians before by physicians. Con-
sented participants were screened by physicians work-
ing in the medical and pediatric outpatient departments. 
Two hundred and sixteen stool specimens were collected 
from eligible patients using clean, sterile, wide-mouthed 
containers, free from disinfectant or detergent residue 
and tight-fitting leak-proof lids. Participants on antibiotic 
treatment at the time of sample collection and those with 
persistence diarrheal were excluded. Socio-demographic 
data were collected using questionnaire based interviews. 
Risk factors for acute diarrhea, and clinical signs and 
symptoms of patients were collected by clinicians during 
examination. Stool specimens were transported using Cary 
Blair transport media in cold box to Medical Microbiology 
laboratory of Mekelle University for further processing.
Isolation and identification of Shigella
MacConkey agar, Xylose Lysine Deosxycholate agar and 
Selenite F enrichment broth (Oxoid, England) were used 
for isolation of Shigella. Culture negative specimens on 
primary solid media were sub-cultured from the enrich-
ment broth to primary solid media to improve recovery 
of the isolates. All inoculated media were incubated at 
37  °C for 18–24  h. After overnight incubation, non-lac-
tose fermenters were further identified by biochemical 
tests using appropriate media namely: Kligler Iron Agar 
for carbohydrate fermentation test, Urea agar for the urea 
utilization test, tryptophan broth for Indole test, Simmon 
Citrate agar for citrate utilization, Motility agar for motil-
ity test, Lysine agar for lysine utilization test (all Oxoid, 
England).
Antimicrobial susceptibility testing
Disk diffusion assay was performed to assess the anti-
biotic resistance/susceptibility pattern of the Shigella 
isolates. Antimicrobial susceptibility testing was car-
ried out on Muller-Hinton agar (Oxoid, England) using 
the single disc diffusion technique against amoxicillin 
(10 μg), chloramphenicol (30 μg), co-trimoxazole (25 μg), 
ciprofloxacin (5  μg), norfloxacin (25  μg), amoxicillin 
(2 μg), amoxicillin clavulanic acid (30 μg) and gentamicin 
(10 μg) (Oxoid, England) based on the Standard Operat-
ing Procedure (SOP) adapted from Clinical and Labora-
tory Standards Institute (CLSI). Susceptibility results 
were reported as sensitive, intermediate and resistant. 
To standardize the inoculum density for a susceptibility 
test, BaSO4 turbidity standard, equivalent to a 0.5 McFar-
land standard was used by strictly following the SOP for 
the preparation and standardization [21]. An isolate was 
defined as multidrug resistant if it was resistant to three 
or more antimicrobial agents tested [22]. An isolate was 
defined as being multidrug resistant if it is resistant to 
three or more of the antimicrobial agents tested [20].
Quality control and data analysis
A standard bacteriological procedure was followed to 
keep the quality of all laboratory tests. American Type 
Culture Collection (ATCC) strains (Shigella sonni ATCC 
25331 and Escherichia coli ATCC 25922) were used as 
control strains for the culture and sensitivity testing. Data 
were entered and analyzed using SPSS version 20 for 
windows. Chi square test results were employed and p 
value less than 0.05 were considered significant.
Ethical consideration
Ethical clearance was obtained from the Ethical Review 
Committee of Mekelle University, College of Health Sci-
ences. Written permission was obtained from Tigray 
Regional Health Bureau and Mekelle Hospital and writ-
ten consent was obtained from each participant (parent 
or guardian for children).
Results
Out of the 216 participants, 109 (50.5  %) were male 
and 107 (49.5  %) were female. The age of the study 
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participants ranged from 2  months to 80  years with 
a mean and a SD of 22.39 ± 18.02. Eighty (37 %) of the 
study participants were children up to 15 years old. From 
the total patients with acute diarrhea, 15 (6.9  %) were 
positive for Shigella. Children ≤15  years were more 
infected by shigella (P = 0.005, X2 = 11.52), but no Shi-
gella was isolated from the age group of 31–45 years. Sex 
was not statistically significant with shigellosis in this 
study (P = 0.76, X2 = 0.093) (Table 1.)
One hundred fifty (69.4  %) of the study participants 
visited the hospital 1–5 days after the onset of diarrhea. 
Ninety-three (43.1  %) and 78 (36.1) of the participants 
had mucoid and watery diarrhea respectively. Private toi-
let and pipe water source were available in 169 (78.2 %) 
and 154 (71.3 %) respectively. Absence of latrine at home 
(p  =  0.002), source of drinking water (p  =  0.027), and 
hand washing habit before meal (p = 0.029) were statis-
tically significant with shigellosis. Eleven (8.6  %) of the 
positive patients reported no vomiting while abdomi-
nal cramp was manifested by 11 (8.1  %) of the positive 
patients (Table 2).
Antimicrobial susceptibility pattern in this study 
showed that Shigella isolates were highly resistant to 
amoxicillin (100 %), amoxicillin (86.7 %) and cotrimoxa-
zole (66.6 %). Low resistance was observed to ciprofloxa-
cin and norfloxacin (6.7 % each), gentamicin (13.3 %) and 
amoxicillin clavulanic acid (33.3 %) (Fig. 1).
Antibiogram pattern in this study revealed that 12 
(80  %) of the isolates were multidrug resistance (resist-
ance for more than two antibiotics) while none of them 
was sensitive to all antimicrobial drugs tested. Four 
(26.7 %) of the Shigella isolates have developed resistance 
to three antimicrobials. Eight of the isolates were resist-
ant to 4 antibiotics and one isolates was resistant to five, 
one for six antibiotics (Table 3).
There is a gradual decreasing of Shigella prevalence 
in the country over time; though it is not uniform in all 
parts of the study areas. However, drug resistant level 
of Shigella isolates is increasing especially for the orally 
administered antimicrobials treatments (Table 4).
Discussion
The isolation rate of Shigella (6.9  %) in our study was 
comparable to previous studies in Ethiopia (Gondar,7.4 % 
[11], Harar 6.4 % [14] Hawassa 7 % [13], Addis Ababa 5 % 
[23]) and other countries, Nigeria, 7.7  % [24] Trinidad 
8 % [5], Iran 8.8 % [25] and Western Nepal 6.88 % [26].
Our prevalence was however; lower when compared 
to studies conducted in other parts of Ethiopia (Jimma, 
Table 1 Prevalence of  Shigella by  age and  gender 
among  outpatients with  acute diarrhea at  Mekelle hospi-
tal, (August–November, 2014)






 Male 109 (50.9) 7 (6.4) 0.093 0.76
 Female 107 (49.5) 8 (7.5)
Age of patients (in years)
 ≤15 80 (37) 10 (12.5) 11.52 0.005
 16-30 82 (38) 2 (2.4)
 31–45 29 (13.4) 0 (0.0)
 ≥46 25 (11.6) 3 (12)
Table 2 Prevalence of  Shigella by  clinical symptoms 
and risk factors among acute diarrhea patients at Mekelle 
hospital (August to November, 2014)
NA not applicable as they are not predisposing factors




 Yes 87 (40.3) 7 (8) NA NA
 No 129 (59.7) 8 (6.2)
Vomiting
 Yes 88 (40.7) 4 (4.5) NA NA
 No 128 (59.3) 11 (8.6)
Abdominal cramp
 Yes 136 (63) 11 (8.1) NA NA
 No 80 (37) 4 (5)
Duration of diarrhea
 1–5 days 150 (69.4) 6 (4) NA NA
 6–10 days 34 (15.7) 4 (11.8)
 11–14 days 32 (14.8) 5 (15.6)
Consistency of diarrhea
 Watery 78 (36.1) 5 (6.4) NA NA
 Mucus 93 (43.1) 2 (2.2)
 Bloody 19 (8.8) 4 (21.1)
 Mucus + blood 26 (12) 4 (15.4)
Presence of latrine at home
 Yes 169 (78.2) 7 (4.1)
 No 47 (21.8) 8 (17) 7.5 0.002
Source of drinking water
 Private pipe 
water
154 (71.3) 6 (3.9)
 Public pipe 
water
37 (17.1) 6 (16.2)
 Well 25 (11.6) 3 (12) 9.19 0.027
Hand washing habit before meal
 Yes 154 (71.3) 7 (4.5)
 No 62 (28.7) 8 (12.9) 4.78 0.029
Hand washing habit
 With soap 36 (23.4) 1 (2.8)
 Without soap 118 (76.6) 6 (5.1) 0.338 0.561
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20.1 % [7] Gondar 16.8 % [10] and Bahir Dar,14.5 % [15] ), 
Nepal 13.61 % [27] and India 12.1 % [19]. Our prevalence 
was slightly higher than studies conducted from Ethio-
pia: Jimma, 2.3  % [8] Gondar, 4.57  % [12] and Butajira, 
4.5 % [28]. Differences insanitation and personal hygiene, 
access to safe drinking water and methodology (sample 
size, study participants, study design) may be the possible 
reasons for the variation in the prevalence.
The variation in the prevalence of Shigella over time in 
the study area could not be detailed in this study due to 
the absence of previous studies from Mekelle town and 
Tigray regional state. However, the pattern of shigellosis 
in other parts of Ethiopia has shown a decreasing trend 
in prevalence overtime though the decrement is not 
uniform. That could be due to the improved awareness 
of the community about personal and environmental 
hygiene from the continuous interventions made by the 
health extension workers implemented by the Ethiopian 
government, and improved supply of safe drinking water.
Although majority of the study participants recruited 
were 16–45 years of age, only 2 (2.4 %) were positive for 
Shigella. Higher positivity for Shigella was recorded from 
children up to 15  years. This was similar to the report 
from Gondar [11]. This may be due to their substandard 
personal hygiene, low immune resistance and more expo-
sure to unavailability of safe water for drinking and wash-
ing hands in school compounds.
About two-third of the study participants came to the 
hospital 1–5  days after the onset of diarrhea yet, high 
rates of Shigella species were found among study partici-
pants diarrhea who reported 11–14 days after their onset 
of diarrhea. This long time before seeking health services 
may contribute for the spread of the pathogen in the 
community.
Abdominal pain, vomiting and fever were the predomi-
nant symptoms of culture positive Shigella cases in this 
study. Similar results have been reported from other 
studies [29]. This is due to the ability of the bacteria to 
invade and replicate in cells lining the colon and rectum, 
patients with bloody diarrhea and mixed (mucus and 
blood) in this study were more positive to Shigella. This 
was in contrary to results from other parts of Ethiopia 
[13, 28]. This difference may result from differences of the 
species involved: Shigella dysentery and Shigella sonnei 
cause bloody and watery diarrhea respectively. Absence 
of latrine at home, source of drinking water, failure to 
Fig. 1 Antimicrobial resistance patterns of Shigella isolates from diar-
rheic outpatients at Mekelle hospital (August to November, 2014)
Table 3 Multidrug resistance pattern of Shigella isolates from outpatients with acute diarrhea at Mekelle hospital (Sep-
tember to November, 2014)
AMP amoxicillin, C chloramphenicol, AML amoxicillin, AMC amoxicillin clavulanic acid, SXT sulphamethoxazole trimethoprim, NOR norfloxacin, CIP ciprofloxacin, CN 
gentamicin
a Ro, R1,R2,R3,R4,R5,R6 = Sensitive to all, resistant to one, two, three, four, five and six antibiotics respectively
Number of antimicrobial resistance Shigella species
Resistance antibiograma Number of isolates (%)
Ro None None
R1 AMP 1 (6.7)
R2 AMP, AML 1 (6.7)
AMP, AMC 1 (6.7)
R3 AMP, C, AML 1 (6.7)
AMP, AML, SXT 1 (6.7)
R4 AMP, C, AML, SXT 4 (26.7)
AMP, AML, AMC, SXT 3 (20)
AMP, C, AML, AMC 1 (6.7)
R5 AMP, AML, SXT, CIP, CN 1 (6.7)
R6 AMP, C, AML, SXT, NOR, CN 1 (6.7)
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wash hands before meals were found significantly associ-
ated with shigellosis; which is similar with reports from 
elsewhere [13, 14, 19]
Antimicrobial resistance pattern and prevalence of Shi-
gella in this study are compared with previous findings 
from other parts of the country are shown in Table 4. The 
resistance patterns of antimicrobial drugs to Shigella in 
the present study ranges from amoxicillin (100 %) to cip-
rofloxacin and norfloxacin (6.7  % each). The resistance 
pattern amoxicillin in this study was similar with studies 
carried out in other regions of Ethiopia (Jimma [8] and 
Harar [14]), India [19] and Iran [20]. The rise in resist-
ance may be due to ease of availability and repeated use 
for many years.
In this study (13.3 %) of the isolates were Gentamicin 
resistant; this was similar to the study done in Gonder 
(12.2 %) [18] and Butajira (17.6 %) [28]. However, results 
obtained from Addis Ababa [30], and Harar [14] showed 
no resistance to Gentamicin. Unlike to our results, how-
ever; relatively high resistant isolates for gentamicin were 
recorded from Bahir Dar (25  %) [15], Hawassa (27.3  %) 
[13] and Gondar (41.7  %) [12]. This indicates emerging 
of gentamicin drug resistance Shigella isolates over time. 
This was clearly seen in Gonder where gentamicin resist-
ance is increasing from 7.9 % in 2006 9 to 41.7 % in 2014 
[12].
Low level Shigella resistance to ciprofloxacin 6.7  % 
were observed in this study similar to studies from Ethi-
opia (Bahir Dar (0.0  %) [15], Hawassa (0.0  %) [13] and 
Gondar (0.0 %) [12], Brazil (0.0 %), [31] Iran (0.0 %), [20] 
Ghana (0.0 %) [32]. However, results from other countries 
showed high resistance to ciprofloxacin: India (82 %), [19] 
Western Nepal 47.8 % [26], Nepal 28.3 % [33] and China 
25.2 % [32]). High resistance (86.7 %) of Shigella was also 
seen to amoxicillin in this study which was similar to the 
report from Bahir Dar 88.2 % [15].However, higher resist-
ance than this study were reported from Hawassa 100 % 
[13], Jimma 100 % [7] and Harar 100 % [14] which could 
be due to the variation in clinicians’ prescription of the 
antibiotic for the treatment of patients.
High resistance was also observed to co-trimoxazole 
66.7  %, which agrees with the reports from Gonder 
73.4  % [10], North West Ethiopia 84.6  % [11], Butajira 
76.5 % [28], Jimma 100 % [7] in contrast to low resistance 
report from Hawassa (56.0 %) [13].This increase of resist-
ance from those reports indicated that aggravating prob-
lem of drug resistance by these microbes over the years. 
This may be due to misuse or inappropriate use of drugs.
Anti biogram patterns revealed that none of the Shi-
gella isolates in the present study were sensitive to all 
tested antibiotics. However, 80 % of the isolates showed 
multidrug resistance (resistance for more than two anti-
biotics) (Table  3). This shows that even if antibiotics 
have revolutionized the treatment of common bacterial 
infections and played a crucial role in reducing mortal-
ity, there is rapid increase in antibiotic resistance among 
Shigella pathogens in developing countries which needs 
is critical attention.
The overuse and misuse of antibiotics in the treatment 
of diarrhea could lead to an increase of antibiotic resist-
ance [14, 34]. Limited laboratory diagnosis in developing 
countries imposes clinicians to syndromaic diagnosis and 
empirical prescription of broad spectrum antibiotics that 
led drug resistant bacterial strains to emerge [35].
The strength of this study compared to previous studies 
on Shigella is in the design of the study. Our study was 
conducted prospectively in a manner of controlled data 
collection and laboratory tests, whereas the other studies 
were conducted retrospectively: Awassa [13], Gondar [9, 
11] Jimma [7] and Addis Ababa [30]. This study may not 
Table 4 Pattern of prevalence and antimicrobial resistance patterns of Shigella reported from 2001 to 2014 in Ethiopia
AMP amoxicillin, C chloramphenicol, AML amoxycillin, AMC amoxycillin Clavulanic acid, SXT sulphamethoxazole trimethoprim, NOR norfloxacin, CIP ciprofloxacin, CN 
gentamicin
Study area Authors Prevalence Amp Cot C NOR CIP CN AMC AMX
Gondar Yismaw et al. [9] 7.4 79.9 73.4 52.2 – 8.9 7.9 – –
Huruy et al. [10] 16.8 81.5 75.4 50.8 – 9.2 10.7 – –
Tiruneh [11] 7.5 78.9 84.6 67.8 1.1 2.2 12.2 – –
Demissie et al. [12] 4.57 94.1 58.8 17.6 – 0.0 41.7 – –
Harar Reda et al. [14] 6.7 100 5.9 29.4 – – 0.0 – 100
Bahir Dar Debas et al. [15] 14.5 – – – 9.4 0.0 25 – 88.2
Hawassa Mulatu et al. [13] 7 63 0.0 9.1 – 0.0 27.3 – 100
Butajira Mengstu et al. [29] 4.5 47.1 76.5 29.4 – 5.9 17.6 – –
Jimma Mache [7] 20.1 70.1 32.5 40.3 1.3 – –
Beyene and Tasew [8] 2.3 100 100 16.7 – – 0.0 – 100
Mekelle This study 6.9 100 66.7 46.7 6.7 6.7 13.3 33.3 86.7
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necessarily be representative of the community preva-
lence of the disease, because the sample size is small.
Conclusion
Shigellosis in this study was 6.9  %. Children under 
15 years were highly infected. Source of drinking water, 
presence of latrine in their compound and hand washing 
habit before meal were found as risk factors. Shigella iso-
lates were high resistant to amoxicillin 100 and 66 % cot-
rimoxazole. Ciprofloxacin, norfloxacin and gentamicin 
were found highly sensitive for Shigella isolates. More 
emphasis should be given towards supply of safe water 
and health education for the community. Accurate diag-
nosis during management of infection caused by Shigella 
should be employed than empirical treatment of patients. 
Periodic epidemiological surveillance is of great impor-
tance to control the diseases and MDR of Shigella spp.
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